Based on these data, the Idylla IDH1-2 mutation assay represents a fast and reliable alternative to detect <i>IDH</i> hotspot variants in solid tumors and hematological malignancies using either fixed tissue sections or DNA extracts. Here, IDH2 is linked to hematologic disorder.